UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date of report (Date of earliest event reported): January 29, 2025
Regional Health Properties, Inc.
(Exact Name of Registrant as Specified in its Charter)
Georgia |
|
001-33135 |
|
81-5166048 |
(State
or Other Jurisdiction of |
|
(Commission |
|
(I.R.S.
Employer |
Incorporation) |
|
File
Number) |
|
Identification
No.) |
1050 Crown Pointe Parkway
Suite 720
Atlanta, Georgia 30338
(Address of Principal Executive Offices, and Zip Code)
(678) 869-5116
(Registrant’s telephone number, including area code)
Not
applicable.
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
☒ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
Common
Stock, no par value |
|
RHE |
|
NYSE
American |
Series
A Redeemable Preferred Shares, no par value |
|
RHE-PA |
|
NYSE
American |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)
or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On
January 29, 2025, the board of directors of Regional Health Properties, Inc. (“Regional”) declared a dividend (the “Dividend”)
to the holders of its 12.5% Series B Cumulative Redeemable Preferred Shares (the “Series B Preferred Stock”), on a pro rata
basis in proportion to the number of shares of Series B Preferred Stock held by such holders, of 250,000 shares of the Company’s
common stock (“Common Stock”), rounded down to the nearest whole share of Common Stock. The dividend will be paid on or about
February 19, 2025 to holders of record of the Series B Preferred Stock as of the close of business on February 10, 2025. Regional is
required to pay the dividend of Common Stock to such holders of Series B Preferred Stock pursuant to the terms of Regional’s Amended
and Restated Articles of Incorporation, which governs the terms of the Series B Preferred Stock.
On
January 30, 2025, Regional issued a press release announcing the Dividend. A copy of that press release is filed as Exhibit 99.1 to this
Current Report on Form 8-K and incorporated herein by reference.
Item
9.01. | Financial
Statements and Exhibits. |
(d)
Exhibits
*
* *
NO
OFFER OR SOLICITATION
Communications
in this Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation
of any proxy vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall
be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act.
ADDITIONAL
INFORMATION
The
proposed merger will be submitted to both the Regional and the SunLink Health Systems, Inc., a Georgia corporation (“SunLink”),
shareholders for their consideration. In connection with the proposed merger, Regional will file a Registration Statement on Form S-4
(the “Registration Statement”) with the SEC that will include a joint proxy statement/prospectus for Regional and SunLink
and other relevant documents concerning the proposed merger.
INVESTORS
ARE URGED TO READ THE REGISTRATION STATEMENT AND THE CORRESPONDING JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED MERGER WHEN
IT BECOMES AVAILABLE, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, TOGETHER WITH ALL AMENDMENTS AND SUPPLEMENTS TO THOSE
DOCUMENTS, AS THEY WILL CONTAIN IMPORTANT INFORMATION.
You
will be able to obtain a copy of the joint proxy statement/prospectus once filed, as well as other filings containing information about
Regional and SunLink, without charge, at the SEC’s website (http://www.sec.gov) or by accessing Regional’s website (http://www.regionalhealthproperties.com)
under the tab “Investor Relations” or by accessing SunLink’s website (http://www.sunlinkhealth.com) under the tab “Investors.”
Copies of the joint proxy statement/prospectus and the filings with the SEC that will be incorporated by reference in the joint proxy
statement/prospectus can also be obtained, without charge, by directing a request to Investor Relations, Regional Health Properties,
Inc., 1050 Crowne Point Parkway, Suite 720, Atlanta, Georgia, 30338, telephone 678-869-5116 or to Investor Relations, SunLink Health
Systems, Inc., 900 Circle 75 Parkway, Suite 690, Atlanta, Georgia, 30339, telephone 770-933-7004.
Regional
and SunLink and certain of their directors and executive officers may be deemed to be participants in the solicitation of proxies from
the shareholders of Regional and SunLink in connection with the proposed merger. Information about the directors and executive officers
of Regional is set forth in the Proxy Statement, which information may be updated by Regional from time to time in subsequent filings
with the SEC. Information about the directors and executive officers of SunLink is set forth in the proxy statement for SunLink’s
2024 annual meeting of shareholders, as filed with the SEC on Schedule 14A on June 6, 2024, which information may be updated by SunLink
from time to time in subsequent filings with the SEC. Additional information about the interests of those participants and other persons
who may be deemed participants in the transaction may also be obtained by reading the joint proxy statement/prospectus relating to the
proposed merger when it becomes available. Free copies of this document may be obtained as described above.
Cautionary
Note Regarding Forward-Looking Statements
This
Current Report on Form 8-K contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E of the Exchange Act. Such forward-looking statements
can often, but not always, be identified by the use of words like “believe”, “continue”, “pattern”,
“estimate”, “project”, “intend”, “anticipate”, “expect” and similar expressions
or future or conditional verbs such as “will”, “would”, “should”, “could”, “might”,
“can”, “may”, or similar expressions. These forward-looking statements include, but are not limited to, statements
relating to the payment of a Common Stock dividend to holders of Regional’s Series B Preferred Stock; the expected timing and benefits
of the proposed merger between Regional and SunLink, including future financial and operating results, cost savings, enhanced revenues,
and accretion/dilution to reported earnings that may be realized from the merger, as well as other statements of expectations regarding
the merger, and other statements of Regional’s goals, intentions and expectations; statements regarding Regional’s business
plan and growth strategies; estimates of Regional’s risks and future costs and benefits, whether with respect to the merger or
otherwise; and the payment of a cash dividend by SunLink.
These
forward-looking statements are subject to significant risks, assumptions and uncertainties that may cause results to differ materially
from those set forth in forward-looking statements, including, among other things:
|
● |
the
risk that the businesses of Regional and SunLink will not be integrated successfully or such integration may be more difficult, time-consuming
or costly than expected; |
|
|
|
|
● |
expected
revenue synergies and cost savings from the merger may not be fully realized or realized within the expected time frame; |
|
|
|
|
● |
revenues
following the merger may be lower than expected; |
|
|
|
|
● |
customer,
vendor and employee relationships and business operations may be disrupted by the merger; |
|
|
|
|
● |
the
ability to obtain required regulatory approvals or the approvals of Regional’s or SunLink’s shareholders, and the ability
to complete the merger on the expected timeframe; |
|
|
|
|
● |
the
costs and effects of litigation and the possible unexpected or adverse outcomes of such litigation; |
|
|
|
|
● |
the
ability of Regional and SunLink to meet the continued listing requirements of the NYSE American LLC and to maintain the listing of
securities thereon; |
|
|
|
|
● |
possible
changes in economic and business conditions; |
|
|
|
|
● |
the
impacts of epidemics, pandemics or other infectious disease outbreaks; |
|
|
|
|
● |
the
existence or exacerbation of general geopolitical instability and uncertainty; |
|
|
|
|
● |
possible
changes in monetary and fiscal policies, and laws and regulations; |
|
● |
competitive
factors in the healthcare industry; |
|
|
|
|
● |
Regional’s
dependence on the operating success of its operators; |
|
|
|
|
● |
the
amount of, and Regional’s ability to service, its indebtedness; |
|
|
|
|
● |
covenants
in Regional’s debt agreements that may restrict its ability to make investments, incur additional indebtedness and refinance
indebtedness on favorable terms; |
|
|
|
|
● |
the
effect of increasing healthcare regulation and enforcement on Regional’s operators and the dependence of Regional’s operators
on reimbursement from governmental and other third-party payors; |
|
|
|
|
● |
the
relatively illiquid nature of real estate investments; |
|
|
|
|
● |
the
impact of litigation and rising insurance costs on the business of Regional’s operators; |
|
|
|
|
● |
the
effect of Regional’s operators declaring bankruptcy, becoming insolvent or failing to pay rent as due; |
|
|
|
|
● |
the
ability of any of Regional’s operators in bankruptcy to reject unexpired lease obligations and to impede its ability to collect
unpaid rent or interest during the pendency of a bankruptcy proceeding and retain security deposits for the debtor’s obligations; |
|
|
|
|
● |
Regional’s
ability to find replacement operators and the impact of unforeseen costs in acquiring new properties; and |
|
|
|
|
● |
other
risks and factors identified in (i) Regional’s cautionary language included under the headings “Statement Regarding Forward-Looking
Statements” and “Risk Factors” in Regional’s Annual Report on Form 10-K for the year ended December 31, 2023,
and other documents subsequently filed by Regional with the SEC and (ii) SunLink’s cautionary language included under the headings
“Forward-Looking Statements” and “Risk Factors” in SunLink’s Annual Report on Form 10-K for the year
ended June 30, 2024, and other documents subsequently filed by SunLink with the SEC. |
Neither
Regional nor SunLink undertake any obligation to update any forward-looking statement, whether written or oral, relating to the matters
discussed in this Current Report on Form 8-K. In addition, Regional’s and SunLink’s past results of operations do not necessarily
indicate either of their anticipated future results, whether the merger is effectuated or not.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
REGIONAL
HEALTH PROPERTIES, INC. |
|
|
Date:
January 30, 2025 |
/s/
Brent Morrison |
|
Brent
Morrison |
|
Chief
Executive Officer and President |
Exhibit
99.1
![](https://www.sec.gov/Archives/edgar/data/1004724/000149315225004264/ex99-1_001.jpg)
Regional
Health Properties, Inc. Announces Distribution of Common Stock to Holders of its 12.5% Series B Cumulative Redeemable Preferred Shares
Atlanta,
GA (January 30, 2025) - Regional Health Properties, Inc. (“Regional”) (NYSE American: RHE) (NYSE American: RHE-PA) announced
today that its Board of Directors declared a dividend to the holders of its 12.5% Series B Cumulative Redeemable Preferred Shares (the
“Series B Preferred Stock”), on a pro rata basis in proportion to the number of shares of Series B Preferred Stock held by
such holders, of 250,000 shares of the Company’s common stock (“Common Stock”), rounded down to the nearest whole share
of Common Stock. The dividend will be paid on or about February 19, 2025 to holders of record of the Series B Preferred Stock as of the
close of business on February 10, 2025. Regional is required to pay the dividend of Common Stock to such holders of Series B Preferred
Stock pursuant to the terms of Regional’s Amended and Restated Articles of Incorporation, which governs the terms of the Series
B Preferred Stock.
The
distribution of shares of Common Stock will be made in book entry form, and no physical share certificates of Common Stock will be issued.
Series
B Preferred Stock shareholders will not be required to pay cash or other consideration for the shares of Common Stock to be distributed
to them or to surrender or exchange their shares of Series B Preferred Stock to receive the distribution.
About
Regional Health Properties
Regional
Health Properties, Inc., headquartered in Atlanta, Georgia, is a self-managed healthcare real estate investment company that invests
primarily in real estate purposed for senior living and long-term care. For more information, visit https://www.regionalhealthproperties.com.
NO
OFFER OR SOLICITATION
Communications
in this press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of
any proxy vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities shall be
made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended (the “Securities
Act”).
ADDITIONAL
INFORMATION
The
proposed merger of SunLink Health Systems, Inc., a Georgia corporation (“SunLink”), with and into Regional, with Regional
surviving the merger, will be submitted to both the Regional and SunLink shareholders for their consideration. In connection with the
proposed merger, Regional will file a Registration Statement on Form S-4 (the “Registration Statement”) with the SEC that
will include a joint proxy statement/prospectus for Regional and SunLink and other relevant documents concerning the proposed merger.
INVESTORS
ARE URGED TO READ THE REGISTRATION STATEMENT AND THE CORRESPONDING JOINT PROXY STATEMENT/PROSPECTUS REGARDING THE PROPOSED MERGER WHEN
IT BECOMES AVAILABLE, AS WELL AS ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC, TOGETHER WITH ALL AMENDMENTS AND SUPPLEMENTS TO THOSE
DOCUMENTS, AS THEY WILL CONTAIN IMPORTANT INFORMATION.
You
will be able to obtain a copy of the joint proxy statement/prospectus once filed, as well as other filings containing information about
Regional and SunLink, without charge, at the SEC’s website (http://www.sec.gov) or by accessing Regional’s website (http://www.regionalhealthproperties.com)
under the tab “Investor Relations” or by accessing SunLink’s website (http://www.sunlinkhealth.com) under the tab “Investors.”
Copies of the joint proxy statement/prospectus and the filings with the SEC that will be incorporated by reference in the joint proxy
statement/prospectus can also be obtained, without charge, by directing a request to Investor Relations, Regional Health Properties,
Inc., 1050 Crowne Point Parkway, Suite 720, Atlanta, Georgia, 30338, telephone 678-869-5116 or to Investor Relations, SunLink Health
Systems, Inc., 900 Circle 75 Parkway, Suite 690, Atlanta, Georgia, 30339, telephone 770-933-7004.
Regional
and SunLink and certain of their directors and executive officers may be deemed to be participants in the solicitation of proxies from
the shareholders of Regional and SunLink in connection with the proposed merger. Information about the directors and executive officers
of Regional is set forth in the proxy statement for Regional’s 2024 annual meeting of shareholders, as filed with the SEC on Schedule
14A on December 13, 2024, which information may be updated by Regional from time to time in subsequent filings with the SEC. Information
about the directors and executive officers of SunLink is set forth in the proxy statement for SunLink’s 2024 annual meeting of
shareholders, as filed with the SEC on Schedule 14A on June 6, 2024, which information may be updated by SunLink from time to time in
subsequent filings with the SEC. Additional information about the interests of those participants and other persons who may be deemed
participants in the transaction may also be obtained by reading the joint proxy statement/prospectus relating to the proposed merger
when it becomes available. Free copies of this document may be obtained as described above.
Cautionary
Note Regarding Forward-Looking Statements
This
press release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform
Act of 1995, Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking
statements can often, but not always, be identified by the use of words like “believe”, “continue”, “pattern”,
“estimate”, “project”, “intend”, “anticipate”, “expect” and similar expressions
or future or conditional verbs such as “will”, “would”, “should”, “could”, “might”,
“can”, “may”, or similar expressions. These forward-looking statements include, but are not limited to, statements
relating to the payment of a Common Stock dividend to holders of Regional’s Series B Preferred Stock; the expected timing and benefits
of the proposed merger between Regional and SunLink, including future financial and operating results, cost savings, enhanced revenues,
and accretion/dilution to reported earnings that may be realized from the merger, as well as other statements of expectations regarding
the merger, and other statements of Regional’s goals, intentions and expectations; statements regarding Regional’s business
plan and growth strategies; estimates of Regional’s risks and future costs and benefits, whether with respect to the merger or
otherwise; and the payment of a cash dividend by SunLink.
These
forward-looking statements are subject to significant risks, assumptions and uncertainties that may cause results to differ materially
from those set forth in forward-looking statements, including, among other things:
| ● | the
risk that the businesses of Regional and SunLink will not be integrated successfully or such
integration may be more difficult, time-consuming or costly than expected; |
| | |
| ● | expected
revenue synergies and cost savings from the merger may not be fully realized or realized
within the expected time frame; |
| | |
| ● | revenues
following the merger may be lower than expected; |
| | |
| ● | customer,
vendor and employee relationships and business operations may be disrupted by the merger; |
| | |
| ● | the
ability to obtain required regulatory approvals or the approvals of Regional’s or SunLink’s
shareholders, and the ability to complete the merger on the expected timeframe; |
| | |
| ● | the
costs and effects of litigation and the possible unexpected or adverse outcomes of such litigation; |
| | |
| ● | the
ability of Regional and SunLink to meet the continued listing requirements of the NYSE American
LLC and to maintain the listing of securities thereon; |
| | |
| ● | possible
changes in economic and business conditions; |
| | |
| ● | the
impacts of epidemics, pandemics or other infectious disease outbreaks; |
| ● | the
existence or exacerbation of general geopolitical instability and uncertainty; |
| | |
| ● | possible
changes in monetary and fiscal policies, and laws and regulations; |
| | |
| ● | competitive
factors in the healthcare industry; |
| | |
| ● | Regional’s
dependence on the operating success of its operators; |
| | |
| ● | the
amount of, and Regional’s ability to service, its indebtedness; |
| | |
| ● | covenants
in Regional’s debt agreements that may restrict its ability to make investments, incur
additional indebtedness and refinance indebtedness on favorable terms; |
| ● | the
effect of increasing healthcare regulation and enforcement on Regional’s operators
and the dependence of Regional’s operators on reimbursement from governmental and other
third-party payors; |
| | |
| ● | the
relatively illiquid nature of real estate investments; |
| | |
| ● | the
impact of litigation and rising insurance costs on the business of Regional’s operators; |
| | |
| ● | the
effect of Regional’s operators declaring bankruptcy, becoming insolvent or failing
to pay rent as due; |
| | |
| ● | the
ability of any of Regional’s operators in bankruptcy to reject unexpired lease obligations
and to impede its ability to collect unpaid rent or interest during the pendency of a bankruptcy
proceeding and retain security deposits for the debtor’s obligations; |
| | |
| ● | Regional’s
ability to find replacement operators and the impact of unforeseen costs in acquiring new
properties; and |
| | |
| ● | other
risks and factors identified in (i) Regional’s cautionary language included under the
headings “Statement Regarding Forward-Looking Statements” and “Risk Factors”
in Regional’s Annual Report on Form 10-K for the year ended December 31, 2023, and
other documents subsequently filed by Regional with the SEC and (ii) SunLink’s cautionary
language included under the headings “Forward-Looking Statements” and “Risk
Factors” in SunLink’s Annual Report on Form 10-K for the year ended June 30,
2024, and other documents subsequently filed by SunLink with the SEC. |
Neither
Regional nor SunLink undertake any obligation to update any forward-looking statement, whether written or oral, relating to the matters
discussed in this press release. In addition, Regional’s and SunLink’s past results of operations do not necessarily indicate
either of their anticipated future results, whether the merger is effectuated or not.
Regional
Contact
Brent
Morrison, CFA
Chief
Executive Officer & President
Regional
Health Properties, Inc.
Tel
(404) 823-2359
Brent.morrison@regionalhealthproperties.com
Regional Health Properties (AMEX:RHE-B)
Historical Stock Chart
From Jan 2025 to Feb 2025
Regional Health Properties (AMEX:RHE-B)
Historical Stock Chart
From Feb 2024 to Feb 2025